48
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Effect of the Ganglionic Segment Inflammatory Response to Postoperative Enterocolitis in Hirschsprung Disease

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 140-150 | Received 08 Nov 2023, Accepted 10 Jan 2024, Published online: 25 Jan 2024

References

  • Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013;25(3):368–74. doi:10.1097/MOP.0b013e328360c2a0.
  • Bealer JF, Natuzzi ES, Buscher C, Ursell PC, Flake AW, Adzick NS, Harrison MR. Nitric oxide synthase is deficient in the aganglionic colon of patients with Hirschsprung’s disease. Pediatrics. 1994;93(4):647–51. doi:10.1542/peds.93.4.647.
  • Wester T, Granström AL. Hirschsprung disease-bowel function beyond childhood. Semin Pediatr Surg. 2017;26(5):322–7. doi:10.1053/j.sempedsurg.2017.09.008.
  • Tomuschat C, O’Donnell AM, Coyle D, Puri P. Increased Act1/IL-17R expression in Hirschsprung’s disease. Pediatr Surg Int. 2016;32(12):1201–7. doi:10.1007/s00383-016-3980-4.
  • Tomuschat C, O’Donnell AM, Coyle D, Puri P. Altered expression of IL36γ and IL36 receptor (IL1RL2) in the colon of patients with Hirschsprung’s disease. Pediatr Surg Int. 2017;33(2):181–6. doi:10.1007/s00383-016-4011-1.
  • Müller I, Kym U, Galati V, Tharakan S, Subotic U, Krebs T, Stathopoulos E, Schmittenbecher P, Cholewa D, Romero P, et al. Cholinergic signaling attenuates pro-ınflammatory ınterleukin-8 response in colonic epithelial cells. Front Immunol. 2021;12:781147. doi:10.3389/fimmu.2021.781147.
  • Imamura A, Puri P, O’Briain DS, Reen DJ. Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut. 1992;33(6):801–6. doi:10.1136/gut.33.6.801.
  • Frykman PK, Short SS. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21(4):328–35. doi:10.1053/j.sempedsurg.2012.07.007.
  • Rentea RM, Welak SR, Fredrich K, Donohoe D, Pritchard KA, Oldham KT, Gourlay DM, Liedel JL. Early enteral stressors in newborns increase inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model. Eur J Pediatr Surg. 2013;23(1):39–47. doi:10.1055/s-0032-1329704.
  • Pastor AC, Osman F, Teitelbaum DH, Caty MG, Langer JC. Development of a standardized definition for Hirschsprung’s-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009;44(1):251–6. doi:10.1016/j.jpedsurg.2008.10.052.
  • Goldstein AM, Thapar N, Karunaratne TB, De Giorgio R. Clinical aspects of neurointestinal disease: pathophysiology, diagnosis, and treatment. Dev Biol. 2016;417(2):217–28. doi:10.1016/j.ydbio.2016.03.032.
  • Mueller JL, Goldstein AM. The science of Hirschsprung disease: what we know and where we are headed. Semin Pediatr Surg. 2022;31(2):151157. doi:10.1016/j.sempedsurg.2022.151157.
  • Gosain A, Frykman PK, Cowles RA, Horton J, Levitt M, Rothstein DH, Langer JC, Goldstein AM, American Pediatric Surgical Association Hirschsprung Disease Interest Group. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517–21. doi:10.1007/s00383-017-4065-8.
  • Roorda D, Oosterlaan J, van Heurn E, Derikx JPM. Risk factors for enterocolitis in patients with Hirschsprung disease: a retrospective observational study. J Pediatr Surg. 2021;56(10):1791–8. doi:10.1016/j.jpedsurg.2021.04.020.
  • Sakurai T, Tanaka H, Endo N. Predictive factors for the development of postoperative Hirschsprung-associated enterocolitis in children operated during infancy. Pediatr Surg Int. 2021;37(2):275–80. doi:10.1007/s00383-020-04784-z.
  • Yitbarek GY, Walle Ayehu G, Asnakew S, Ayele FY, Bariso Gare M, Mulu AT, Dagnaw FT, Melesie BD. The role of C-reactive protein in predicting the severity of COVID-19 disease: a systematic review. SAGE Open Med. 2021;9:20503121211050755. doi:10.1177/20503121211050755.
  • Croft A, Lord A, Radford-Smith G. Markers of systemic ınflammation in acute attacks of ulcerative colitis: what level of C-reactive protein constitutes severe colitis? J Crohns Colitis. 2022;16(7):1089–96. doi:10.1093/ecco-jcc/jjac014.
  • Keck S, Galati-Fournier V, Kym U, Moesch M, Usemann J, Müller I, Subotic U, Tharakan SJ, Krebs T, Stathopoulos E, et al. Lack of mucosal cholinergic ınnervation ıs associated with ıncreased risk of enterocolitis in Hirschsprung’s disease. Cell Mol Gastroenterol Hepatol. 2021;12(2):507–45. doi:10.1016/j.jcmgh.2021.03.004.
  • Tomuschat C, Virbel CR, O’Donnell AM, Puri P. Reduced expression of the NLRP6 inflammasome in the colon of patients with Hirschsprung’s disease. J Pediatr Surg. 2019;54(8):1573–7. doi:10.1016/j.jpedsurg.2018.08.059.
  • Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685–90. doi:10.1038/ni.2608.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.